Articles from NeuroOne Medical Technologies Corporation
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
Major Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical Companies
By NeuroOne Medical Technologies Corporation · Via GlobeNewswire · October 22, 2026
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027
By NeuroOne Medical Technologies Corporation · Via GlobeNewswire · October 8, 2026
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million
By NeuroOne Medical Technologies Corporation · Via GlobeNewswire · October 5, 2026
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. Markets
By NeuroOne Medical Technologies Corporation · Via GlobeNewswire · September 17, 2026